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Supplementary Figure 1: Spleen compartments and infection time-course. CD1 mouse 46 
spleen sections have been stained with three different antibody combinations in order to 47 
show the spleen compartments. In panel a metallophilic CD169+ macrophages (red, Cr-Fc, 48 
AF568b) and B cells + T cells (white, α-B220+α-CD3, both AF647) are shown, in panel b 49 
metallophilic macrophages (red, Cr-Fc, AF568b) and red pulp macrophages (magenta, α-50 
F4/80, AF647), in panel c metallophilic macrophages (red, Cr-Fc, AF568b) and marginal 51 
zone macrophages (yellow, aSIGN-R1b, AF488s). Spleen sections of CD1 mice infected by 52 
S. pneumoniae D39 show an increase of number, and a change in localisation of the foci of 53 
infection over time (white arrows indicate bacterial clusters). After five minutes, single 54 
bacteria (green) can be observed exclusively in the marginal zone (area not stained between 55 
the red pulp in magenta and the metallophilic area in red) (d). At four hours after infection 56 
(e), the majority of the bacteria are cleared and there are only a few foci of pneumococci. At 57 
six hours post-infection (f) an increase in the number and in the size of the foci is observed 58 
in the metallophilic macrophages. At eight hours (g) the number of bacteria in most foci is 59 
much higher and clusters of bacteria can be found throughout the spleen. Bacteria were 60 
stained in green (α-type2, AF488), red pulp macrophages in purple (α-F4/80, AF647), 61 
metallophilic macrophages in red (CR-Fc, AF568) and nuclei in blue (DAPI).  All the 62 
immunofluorescence images are representative of 5 sections from 3 different samples. 63 
Antibody details are in Table S1. 64 
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Supplementary Figure 2: CD169+ splenic macrophages following 8-hour infection with 83 
S. pneumoniae TIGR4 and a D39 non-encapsulated mutant. CD1 mice, infected 84 
intravenously with 1x106 CFU of GFP-expressing non-encapsulated pneumococci, develop 85 
foci of infection in the metallophilic zone macrophages (a). GFP expressing bacteria are 86 
shown in green, CD169+ macrophages in red (CR-Fc, AF568) and nuclei are stained in blue 87 
(DAPI). Panel b shows co-localisation of bacteria, and CD169+ macrophages also occurs in 88 
TIGR4 infected spleens. Mice were infected with 1x106 CFU of TIGR4 pneumococci (green, 89 
α-type4, AF488). Metallophilic macrophages (red) and nuclei (blue) have been stained as 90 
above. All the immunofluorescence images are representative of 5 sections from 3 different 91 
samples.  Antibody details are in Table S1. 92 
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104 
Supplementary Figure 3: Distribution of foci of infection. The figure shows the 105 
distribution of the foci of pneumococci, at 6 h after infection, in the white pulp (WP), the 106 
metallophilic macrophage area (MMM), the marginal zone macrophage area (MZM) and the 107 
red pulp area (RP) of the murine spleen. Three groups of infected mice have been 108 
considered in this analysis: mice infected with high dose (1 x 106 CFU) of wild-type D39 S. 109 
pneumoniae (black bars), mice infected with low dose (1 x 105 CFU) of wild-type D39 S. 110 
pneumoniae (grey bars) and mice infected with 1x106 CFU of the D39 after administration of 111 
anti-CD169 mAb (white bars). The data are shown as percentages of the total number of foci 112 
counted. The counts were obtained from 30 random microscope fields from three 113 
independent infected spleens. Error bars represent Standard deviation. 114 
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Supplementary Figure 4: Quantification of mouse spleen compartments. Fluorescent 131 
images of infected mouse spleens were acquired using a fully motorised Nikon Eclipse Ti 132 
microscope. The representative images were then analysed using ImageJ software to 133 
calculate the area of the different spleen compartments. Different staining combinations 134 
have been used to calculate the area of the different compartments for the red pulp (red, α-135 
F4/80, AF647),  metallophilic area (green, Cr-Fc, AF568b), the marginal zone macrophages 136 
(magenta, α-SIGN-R1, AF568) and the white pulp with a combination of B- and T-cell 137 
markers (white, α-B220+α-CD3, both AF647). For quantification, at least 5 sections for each 138 
staining combination have been analysed. The area of each staining was measured and the 139 
proportion with respect to the area of the section was calculated. In panel D the average 140 
area percentages (error bars represent standard deviation) of the different spleen 141 
compartments are reported. All the immunofluorescence images are representative of 5 142 
sections from 3 different samples.  Antibody details are in Table S1. 143 
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Supplementary Figure 5: CD169 blocking and infection of CD169 knockout mouse 148 
strain. Blocking experiments in CD1 mice are shown in panels a to c while experiments in 149 
CD169 KO C57BL/6 mice are shown in panels f to i. The majority of CD1 mice infected i.v. 150 
with D39, after blocking the CD169 receptor with a specific antibody (Rat IgG2a,k, Clone: 151 
3D6.112), do not develop systemic infection after 72 hours (a). CFU were counted 72 hours 152 
after challenge or earlier if the animal was showing signs of disease (left, Isotype control, 153 
n=10, right, CD169 mAb, n=10). ** P < 0.01, Fisher’s exact test, one tailed.  154 
Immunofluorescence on spleen sections 30 minutes after blocking and challenge is shown in 155 
panel b. The localisation of the antibody used for the blocking of CD169 was revealed using 156 
an Alexafluor 568 secondary antibody (red) showing a specific binding to the metallophilic 157 
macrophages ring. In the green circles, pneumococci (stained in green) can be observed to 158 
do not co-localise with the metallophilc macrophages. At 72h after antibody treatment the 159 
staining of metallophilic macrophages was tested by using only the secondary antibody in 160 
samples pre-treated with an isotype matched control antibody (c) and the anti-CD169 161 
blocking antibody (d). A positive control spleen treated with both anti-CD169 antibody, and 162 
the secondary antibody are also shown (e). Nuclei are staining with DAPI (blue), 163 
Metallophilic macrophages are stained with an alexafluor-567-conjugated secondary 164 
antibody (red), and bacteria are staining with an alexafluor-488-conjugated secondary 165 
antibody (green). Further antibody details can be found in Table S1. Panels f to i report data 166 
on CD169 KO mice. (f) Number of CFU/g of spleen, or CFU/mL of blood from WT (black 167 
symbols, n=9) C57BL/6 mice, or sialoadhesin knock-out mice (red symbols, n=9) 6 hour 168 
after intravenous infection with S. pneumoniae D39. Lines represent the mean while error 169 
bars the standard deviation. (g) Shows the relative distribution of infectious foci in WT and 170 
KO mice to different splenic compartments, normalised against the total area of the spleen 171 
formed from that compartment (5 sections of 3 spleens analysed). Open circles; marginal 172 
zone macrophages, open squares; metallophilic macrophages, open triangles; red pulp 173 
macrophages. Lines represent the mean while error bars the standard deviation. (h) Shows 174 
the number of bacteria in each focus (size of foci) localised to each splenic macrophage 175 
compartment in both WT and KO mice (30 microscope fields from 3 different spleens were 176 
analysed at 60X magnification). Black symbols; WT mice, red symbols; KO mice. (i) 177 
Microscopy on knock-out mice spleen show that despite the lack of CD169, the metallophilic 178 
macrophages are still present in a ring-like structure bind to Cr-Fc (red, Cr-Fc, AF568b), in 179 
magenta red pulp macrophages are also stained (α-F4/80, AF647). In all the graphs lines 180 
represent the mean and error bars the standard deviation. All the immunofluorescence 181 
images are representative of 5 sections from 3 different samples.  Antibody details are in 182 
Table S1. 183 
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Supplementary Table 1:  Antibodies and microscopy reagents  188 
Antibody Abbreviation Specificity Conjugated Catalogue Supplier 
Anti-mouse/human CD45R/B220 α-B220 B cells no 103211 Biolegend 
Anti-mouse CD3 α-CD3 T cells no ab33429 Abcam 
Anti-mouse CD169 (Siglec-1) α-CD169 Metallophilic MΦa no 142401 Biolegend 
Rat IgG2a control IMC N/A no 400501 Biolegend 
CR-Fc CR-Fc Metallophilic MΦ no  66 
Anti-mouse F4/80 α-F4/80 Red pulp MΦ no 14-4801-81 eBioscience 
Anti-mouse SIGN-R1 [ER-TR9] α-SIGN-R1 Marginal zone MΦ no ab37220 abcam 
Anti-mouse [ER-TR9] to SIGN Related 1 
(Biotin) 
α-SIGN-R1b Marginal zone MΦ biotinylated ab51819 abcam 
Anti-mouse Ly-6G (GR1) α-GR1 Neutrophils no 127602 Biolegend 
Anti-porcine CD169 3B11/11 α-CD169p CD169+ MΦ no MCA2316GA Biorad 
Anti-porcine CD163 2A10/11 α-CD163 CD163+ MΦ no MCA2311GA Biorad 
Anti-human CD3 | CD3-12 α-CD3 T cells no 
MCA1477A48
8 
Biorad 
Anti-pneumococcal type 2 capsule α-type2 Bacteria no 16745 
Statens 
Serum Institut 
Anti-pneumococcal type 4 capsule α-type4 Bacteria no 16747 
Statens 
Serum Institut 
Chicken anti-Rabbit IgG (H+L) AF488 Secondary Abb 
Alexa 
Fluor® 488 
A-21441 Thermoscientific 
Goat anti-Rat IgG (H+L) AF568 Secondary Ab 
Alexa 
Fluor® 568 
A-11077 Thermoscientific 
Chicken anti-Rat IgG (H+L) AF647 Secondary Ab 
Alexa 
Fluor® 647 
A-21441 Thermoscientific 
Goat anti-Human IgG (H+L) AF568b Secondary Ab 
Alexa 
Fluor® 568 
A-21090 Life technologies 
Goat anti-Mouse IgG (H+L) AF568c Secondary Ab 
Alexa 
Fluor® 568 
A-11004 Thermoscientific 
Streptavidin 488 Conjugate AF488s Biotin 
Alexa 
Fluor® 488 
S32354 Thermoscientific 
Wheat Germ Agglutinin AF633 Membranes 
Alexa 
Fluor® 633 
11550816 
Molecular 
Probes 
Phalloidin pAF647 Actin 
Alexa 
Fluor® 647 
A22287 Thermoscientific 
a MΦ macrophage, b Ab antibody 189 
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Supplementary Table 2: Detection of GFP and RFP labelled bacteria in splenic foci 192 
sample GFP bacteria RFP bacteria both GFP and RFP 
1.1* 1 2 0 
1.2 2 1 0 
1.3 4 2 0 
1.4 2 0 0 
1.5 5 6 0 
1.6 4 2 0 
1.7 0 4 0 
2.1 3 2 0 
2.2 1 1 0 
2.3 3 5 0 
2.4 2 3 0 
2.5 1 0 0 
2.6 1 2 0 
TOTAL 29 30 0 
* Seven and six samples were analysed respectively from two spleens 193 
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Supplementary Table 3: Primers for construction of strains expressing recombinant 202 
nanA 203 
Name Sequence (5’ – 3’) Target region 
Sial_F1 CCAAGAGATTACTATGCACGA Lectin-like 
domain 
upstream flank 
Sial_R1 AGATTATATCACATTATCCATTAAAAATCAAACCGTTTTCTCTGTTAAAGCCGC 
Sial_R1* CCAATTGAAGGGTTGGAGCCGTTTTCTCTGTTAAAGCCGC 
Sial_F2* GCGGCTTTAACAGAGAAAACGGCTCCAACCCTTCAATTGG Lectin-like 
domain 
downstream 
flank 
Sial_F2 CAAAAGCATAAGGAAAGGGGCCGCTCCAACCCTTCAATTGG 
Sial_R2 TGTTTCAGGAAGTGCCTGC 
Lect_F1 GGATTGAGCAGGAAGTATG Sialidase 
domain 
upstream flank 
Lect_R1 AGATTATATCACATTATCCATTAAAAATCAAACTCGTGCATAGTAATCTCTTGG 
Lect_R1* CGTTTTCTCTGTTAAAGCCGCTCGTGCATAGTAATCTCTTGG 
Lect_F2* CCAAGAGATTACTATGCACGAGCGGCTTTAACAGAGAAAACG Sialidase 
domain 
downstream 
flank 
Lect_F2 CAAAAGCATAAGGAAAGGGGCCGCGGCTTTAACAGAGAAAACG 
Lect_R2 GAAGTAGATATTGCCTAGTAATTGG 
 204 
